Latest Content

Remembering Donald P. Hay, MD, and other deceased psychiatric colleagues.

What are the cultural, religious, philosophical, and psychological factors that differentiate Eastern and Western values regarding assisted suicide and euthanasia?

New analysis links traumatic brain injury to later psychosis, prompting long-term screening and follow-up.

Often the best opportunities for mental health growth come when psychiatry, religions, and spirituality can enhance one another.

A novel form of agomelatine shows positive initial results.

Phase 2 trial of oveporexton for narcolepsy type 1 finds improvement on measures of cognition, in addition to previously demonstrated improved hallmark symptom of nighttime wakefulness.

Lipocine's oral brexanolone (LPCN 1154) for the treatment of postpartum depression failed to meet the primary endpoint in a phase 3 placebo-controlled trial.

Pop psychiatry fuels misdiagnosis of autism or ADHD, delaying psychosis and bipolar treatment—why accurate labels and early meds save lives.

Yesterday, we launched a spaceship the moon for the first time in 53 years. What implications does this journey have for psychiatry?

New initiation of the Brilliance Studies, a phase 3 program evaluating the safety and efficacy of alixorexton compared to placebo in adults with narcolepsy type 1 and type 2.

Explore fresh clinical insights on schizophrenia—mortality, stigma, cannabis links, lifestyle, and new treatments—and share cases for our April series.

Q1 psychiatric pipeline shifts: wins, setbacks, and standout trials in depression, schizophrenia, Alzheimer disease, and narcolepsy—what to watch next.

How will AI influence psychiatry training?